Phreesia EBITDA 2019-2025 | PHR

Phreesia ebitda from 2019 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Phreesia Annual EBITDA
(Millions of US $)
2025 $-28
2024 $-106
2023 $-149
2022 $-93
2021 $-7
2020 $1
2019 $5
2018 $-3
Phreesia Quarterly EBITDA
(Millions of US $)
2025-04-30 $4
2025-01-31 $-1
2024-10-31 $-5
2024-07-31 $-10
2024-04-30 $-12
2024-01-31 $-21
2023-10-31 $-24
2023-07-31 $-30
2023-04-30 $-30
2023-01-31 $-32
2022-10-31 $-33
2022-07-31 $-40
2022-04-30 $-44
2022-01-31 $-40
2021-10-31 $-30
2021-07-31 $-18
2021-04-30 $-5
2021-01-31 $-4
2020-10-31 $-2
2020-07-31 $-1
2020-04-30 $-1
2020-01-31 $0
2019-10-31 $2
2019-07-31 $0
2019-04-30 $0
2019-01-31
2018-10-31 $1
2018-07-31 $-1
2018-01-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.607B $0.420B
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.103B 58.65
Doximity (DOCS) United States $12.505B 55.48
Hims & Hers Health (HIMS) United States $11.626B 96.19
Tempus AI (TEM) United States $10.538B 0.00
IRhythm Technologies (IRTC) United States $5.092B 0.00
Hinge Health (HNGE) United States $4.422B 0.00
Privia Health (PRVA) United States $2.509B 187.09
Inspire Medical Systems (INSP) United States $2.340B 34.41
Enovis (ENOV) United States $1.625B 8.59
10x Genomics (TXG) United States $1.513B 0.00
Omnicell (OMCL) United States $1.416B 27.28
Schrodinger (SDGR) United States $1.410B 0.00
Azenta (AZTA) United States $1.331B 58.06
Clover Health Investments (CLOV) United States $1.109B 0.00
Evolent Health (EVH) United States $1.057B 0.00
Claritev (CTEV) United States $0.934B 0.00
Fulgent Genetics (FLGT) United States $0.623B 0.00
Veradigm (MDRX) United States $0.514B 0.00
Standard BioTools (LAB) United States $0.496B 0.00
Talkspace (TALK) United States $0.418B 125.00
Zepp Health (ZEPP) Netherlands $0.360B 0.00
Carlsmed (CARL) $0.337B 0.00
Butterfly Network (BFLY) United States $0.335B 0.00
TruBridge (TBRG) United States $0.284B 49.76
Nyxoah SA (NYXH) Belgium $0.253B 0.00
Outset Medical (OM) United States $0.227B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.215B 0.00
Health Catalyst (HCAT) United States $0.197B 0.00
KORU Medical Systems (KRMD) United States $0.183B 0.00
CapsoVision (CV) United States $0.182B 0.00
MDxHealth SA (MDXH) Belgium $0.126B 0.00
American Well (AMWL) United States $0.114B 0.00
CareCloud (CCLD) United States $0.113B 5.14
EUDA Health Holdings (EUDA) Singapore $0.097B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.092B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.074B 0.00
Pulmonx (LUNG) United States $0.063B 0.00
111 (YI) China $0.059B 0.00
P3 Health Partners (PIII) United States $0.048B 0.00
HeartBeam (BEAT) United States $0.033B 0.00
Zhongchao (ZCMD) China $0.024B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.021B 0.00
Healthcare Triangle (HCTI) United States $0.020B 0.00
Bullfrog AI Holdings (BFRG) United States $0.012B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.007B 0.00
MSP Recovery (MSPR) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.005B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
PROFUSA (PFSA) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00